Tuesday September 9, 2025
9:00 am Registration & Coffee
Workshop A
9:30 am Commercial Considerations for Digital Pathology Assets Supporting Therapeutics
Synopsis
While the promise of digital pathology is clear, clinical adoption at scale is still out of reach. This workshop will explore the commercial realities of deploying digital pathology tools beyond clinical trials, examining where value is created, who benefits, and how success is measured.
Advancing this field starts with asking the right questions…
Join this workshop to:
- Craft a solution that meets real commercial needs and drives market success
- Unlock powerful insights by engaging the right stakeholders from the start
- Redefine value by embracing solutions that break away from traditional expectations and deliver unexpected impact
12:30 pm Lunch Break & Networking
Workshop B
1:30 pm Defining the Future of Digital Pathology Through Standardization & Practical Implementation
Synopsis
As digital pathology advances from concept to clinical utility, major questions remain around how to standardize technologies, scale adoption, and separate genuine progress from overhyped potential. This workshop will unite industry leaders to explore the real-world implementation of AI and digital pathology platforms – from assay
development and validation, to the evolving role of H&E, to interface fragmentation and the need for interoperable systems. With recent breakthroughs like AI-driven CDx approvals setting the tone, this session will spark critical discussion on what must be done now to ensure these tools move beyond isolated use cases and into routine
practice.
Join this workshop to:
- Explore how to move digital pathology from fragmented pilots to scalable, routine workflows
- Address inconsistencies in assays, scanners, and interfaces that block reliable clinical translation
- Debate the strengths and limitations of H&E and AI approaches, and how to focus on meaningful, defensible applications